Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aerosol Inhalation of the Exosomes Derived From Allogenic COVID-19 T Cell in the Treatment of Early Stage Novel Coronavirus Pneumonia

NCT04389385 is registered in ClinicalTrials.gov with TC Erciyes University as lead sponsor.

NCT NCT04389385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04389385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aerosol Inhalation of the Exosomes Derived From Allogenic COVID-19 T Cell in the Treatment of Early Stage Novel Coronavirus Pneumonia
Lead sponsor
TC Erciyes University
Phase
Phase 1
Overall status
Unknown status
Start date
May 1, 2020
Completion date
May 31, 2021
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, pneumonia